Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hogan

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Urology|August 25, 2011
Results: Survey of pediatric urology electronic medical records-use and perspectivesStephen James Canon, Jody Ann Purifoy, Gerald M Heulitt, et al.
Leukemia & Lymphoma|October 15, 2019
Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experienceFiras Baidoun, Dong Chen, Mrinal Patnaik, et al.
Transfusion|October 9, 2015
ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioningMehrdad Hefazi, Mark Litzow, William Hogan, et al.
Blood Research|July 16, 2014
Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysisMohsin Ilyas Malik, Mark Litzow, William Hogan, et al.
Clinical Transplantation|July 22, 2014
Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myelomaChintan Pandya, Shahrukh Hashmi, Nandita Khera, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Computable Eligibility Criteria through Ontology-driven Data Access: A Case Study of Hepatitis C Virus TrialsHansi Zhang, Zhe He, Xing He, et al.
Leukemia Research|September 28, 2015
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalitiesMehrdad Hefazi, Mustaqeem Siddiqui, Mrinal Patnaik, et al.
Psychosomatics|June 2, 2012
Testing a diathesis-stress model: potential genetic risk factors for development of distress in context of acute leukemia diagnosis and transplantMagdalena Romanowicz, Shawna Ehlers, Denise Walker, et al.
Case Reports in Hematology|September 21, 2017
Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid LeukemiaAbhishek Mangaonkar, Hassan Al Khateeb, Narjust Duma, et al.
Leukemia & Lymphoma|February 22, 2018
Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experienceAref Al-Kali, Ahmed Kamel Abou Hussein, Mrinal Patnaik, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Urology|August 25, 2011
Results: Survey of pediatric urology electronic medical records-use and perspectivesStephen James Canon, Jody Ann Purifoy, Gerald M Heulitt, et al.
Leukemia & Lymphoma|October 15, 2019
Clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (MDS-U): single center experienceFiras Baidoun, Dong Chen, Mrinal Patnaik, et al.
Transfusion|October 9, 2015
ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioningMehrdad Hefazi, Mark Litzow, William Hogan, et al.
Blood Research|July 16, 2014
Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysisMohsin Ilyas Malik, Mark Litzow, William Hogan, et al.
Clinical Transplantation|July 22, 2014
Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myelomaChintan Pandya, Shahrukh Hashmi, Nandita Khera, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Computable Eligibility Criteria through Ontology-driven Data Access: A Case Study of Hepatitis C Virus TrialsHansi Zhang, Zhe He, Xing He, et al.
Leukemia Research|September 28, 2015
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalitiesMehrdad Hefazi, Mustaqeem Siddiqui, Mrinal Patnaik, et al.
Psychosomatics|June 2, 2012
Testing a diathesis-stress model: potential genetic risk factors for development of distress in context of acute leukemia diagnosis and transplantMagdalena Romanowicz, Shawna Ehlers, Denise Walker, et al.
Case Reports in Hematology|September 21, 2017
Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid LeukemiaAbhishek Mangaonkar, Hassan Al Khateeb, Narjust Duma, et al.
Leukemia & Lymphoma|February 22, 2018
Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experienceAref Al-Kali, Ahmed Kamel Abou Hussein, Mrinal Patnaik, et al.
Pageof 11